NVS - What's Been Happening With Cytokinetics Stock? | Benzinga
Cytokinetics, Incorporated (NASDAQ: CYTK) shares are trading lower on Tuesday, pulling back from Monday strength.
What To Know: Cytokinetics stock has had an extraordinary past few weeks, up over 200% in the past month. One of the biggest catalysts moving shares during the stock's December climb was the company's announcement of topline results from its SEQUOIA-HCM, the Phase ...